Literature DB >> 18064363

[Mutations in gyrA and gyrB genes among strains of Gram-negative bacilli isolated from Chilean hospitals and their relation with resistance to fluoroquinolones].

Mery De la Fuente C1, Priscila Dauros S, Helia Bello T, Mariana Domínguez Y, Sergio Mella M, Marcela Sepúlveda A, Raúl Zemelman Z, Gerardo González R.   

Abstract

BACKGROUND: A progressive frequency of resistance to fluoroquinolones is observed among Gram-negative bacilli. AIM: To investigate the mechanism of resistance to fluoroquinolones mediated by mutations affecting gyrA and gyrB genes in strains of Gram negative bacüli isolated from CMean hospitals. MATERIAL AND
METHOD: Minimal inhibitory concentration of fluoroquinolones was determined in 91 randomly selected nalidixic acid-resistant strains of Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa, isolated from hospitals of 12 Chilean cities. Quinolone resistance determining region (QRDR) was amplified by PCR and mutations were determined by restriction fragment length polymorphism (RFLP) and DNA sequencing.
RESULTS: Strains with mutation in codon 83 of gyrA showed decreased susceptibility to ciprofloxacin with MICs ranging from 0.25 to 1024 fig/ml. The sequencing of PCR products for gyrA indicated amino acid changes in the QRDR region. One strain ofE. coli presented a double mutation, in codon 83 Ser to Leu as well as in codon 87 Asp to Asn. In strains ofK. pneumoniae, however, the change of codon 83 was Ser to Tyr, in A. baumannii was Ser to Leu and in P. aeruginosa was Thr to He. No strains with mutations affecting gyrB were found.
CONCLUSIONS: Mutations in codon 83 of gyrA is a frequent genetic event involved in the mechanism leading to decreased susceptibility to fluoroquinolone in strains of Gram-negative bacilli.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18064363     DOI: 10.4067/s0034-98872007000900002

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  4 in total

1.  Mutant prevention concentrations of levofloxacin, pazufloxacin and ciprofloxacin for A. baumannii and mutations in gyrA and parC genes.

Authors:  Chengchun Sun; Junwen Hao; Meiqin Dou; Yanwen Gong
Journal:  J Antibiot (Tokyo)       Date:  2014-11-05       Impact factor: 2.649

2.  Alteration of GyrA amino acid required for ciprofloxacin resistance in Klebsiella pneumoniae isolates in China.

Authors:  Yingmei Fu; Lishuang Guo; Yan Xu; Wenli Zhang; Jiaao Gu; Jianfeng Xu; Xiaobei Chen; Yuehui Zhao; Jiayu Ma; Xinghan Liu; Fengmin Zhang
Journal:  Antimicrob Agents Chemother       Date:  2008-05-27       Impact factor: 5.191

3.  Characterization of Mechanisms Lowering Susceptibility to Flumequine among Bacteria Isolated from Chilean Salmonid Farms.

Authors:  Christopher Concha; Claudio D Miranda; Luz Hurtado; Jaime Romero
Journal:  Microorganisms       Date:  2019-12-14

4.  Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosa.

Authors:  Xinyuan Feng; Zhiqi Zhang; Xiaoxia Li; Yan Song; Jianbang Kang; Donghong Yin; Yating Gao; Nan Shi; Jinju Duan
Journal:  Infect Drug Resist       Date:  2019-02-08       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.